Director/PDMR Shareholding

RNS Number : 4096H

Nanoco Group PLC

15 November 2018

 

15 November 2018

NANOCO GROUP PLC

("Nanoco", the "Group", or the "Company")

Director Share Purchase

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, received notification today that Dr Alison Fielding, a Non-Executive Director of the Group, acquired 47,759 Ordinary shares in the Company as set out below.

Following this transaction, Dr Fielding has a beneficial interest in 91,325 Ordinary Shares, all of which are directly held. This interest represents approximately 0.0319 per cent. of the total voting rights in the Company.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification of Dealing Form

1.	Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")
a)	Name	DR ALISON FIELDING
2.	Reason for the notification: PURCHASE OF ORDINARY SHARES
a)	Position /status	NON-EXECUTIVE DIRECTOR
b)	Initial notification / amendment	INITIAL NOTIFICATION
3.	Details of the Issuer
a)	Name	NANOCO GROUP PLC
b)	LEI code	213800HOSJEZO1KOCV33
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Type of instrument: Identification code	ORDINARY SHARES OF 1O PENCE EACH
		ISIN: GB00B01JLR99
b)	Nature of the transaction	PURCHASE OF ORDINARY SHARES
c)	Price(s) and volume(s)	Price(s) Volume(s) 41.88p 47,759
d)	Aggregated information: - Aggregated volume - Price	Price(s) Volume(s) 41.88p 47,759
e)	Date of the transaction	14 NOVEMBER 2018
f)	Place of the transaction	LONDON STOCK EXCHANGE

For further information, please contact:

Nanoco	Tel: [phone]
Michael Edelman, Chief Executive Officer
Brian Tenner, Chief Operating and Financial Officer
Caroline Watson, Investor Relations Manager	Tel: + 44 (0) 7799 897357
[e-mail]
Peel Hunt	Tel: [phone]
Adrian Trimmings
George Sellar
Guy Pengelley
MHP Communications	Tel: [phone]
Reg Hoare / Giles Robinson / Pete Lambie
[e-mail]

Notes for editors:

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-materials. .Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display and Electronics markets. One of the interesting properties of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD^® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

END

 

 

DSHFKQDDBBDBDDD